453 related articles for article (PubMed ID: 27984109)
1. A Comparison of Secondary Polycythemia in Hypogonadal Men Treated with Clomiphene Citrate versus Testosterone Replacement: A Multi-Institutional Study.
Wheeler KM; Smith RP; Kumar RA; Setia S; Costabile RA; Kavoussi PK
J Urol; 2017 Apr; 197(4):1127-1131. PubMed ID: 27984109
[TBL] [Abstract][Full Text] [Related]
2. Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy.
Ramasamy R; Scovell JM; Kovac JR; Lipshultz LI
J Urol; 2014 Sep; 192(3):875-9. PubMed ID: 24657837
[TBL] [Abstract][Full Text] [Related]
3. Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost.
Taylor F; Levine L
J Sex Med; 2010 Jan; 7(1 Pt 1):269-76. PubMed ID: 19694928
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy.
Ide V; Vanderschueren D; Antonio L
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375030
[TBL] [Abstract][Full Text] [Related]
5. Clomiphene Citrate for the Treatment of Hypogonadism.
Wheeler KM; Sharma D; Kavoussi PK; Smith RP; Costabile R
Sex Med Rev; 2019 Apr; 7(2):272-276. PubMed ID: 30522888
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Safety and Efficacy of Clomiphene Citrate for the Treatment of Hypogonadism.
Krzastek SC; Sharma D; Abdullah N; Sultan M; Machen GL; Wenzel JL; Ells A; Chen X; Kavoussi M; Costabile RA; Smith RP; Kavoussi PK
J Urol; 2019 Nov; 202(5):1029-1035. PubMed ID: 31216250
[TBL] [Abstract][Full Text] [Related]
7. CLOMIPHENE CITRATE IN THE TREATMENT OF IDIOPATHIC OR FUNCTIONAL HYPOGONADOTROPIC HYPOGONADISM IN MEN: A CASE SERIES AND REVIEW OF THE LITERATURE.
Liel Y
Endocr Pract; 2017 Mar; 23(3):279-287. PubMed ID: 27849376
[TBL] [Abstract][Full Text] [Related]
8. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy.
Lundy SD; Parekh NV; Shoskes DA
J Sex Med; 2020 Jul; 17(7):1297-1303. PubMed ID: 32307242
[TBL] [Abstract][Full Text] [Related]
9. Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia.
Rotker KL; Alavian M; Nelson B; Baird GL; Miner MM; Sigman M; Hwang K
Asian J Androl; 2018; 20(2):195-199. PubMed ID: 29205178
[TBL] [Abstract][Full Text] [Related]
10. Selective modulation of estrogen receptor in obese men with androgen deficiency: A systematic review and meta-analysis.
Tienforti D; Castellini C; Di Giulio F; Totaro M; Dalmazio G; Spagnolo L; Muselli M; Corona G; Baroni MG; Barbonetti A
Andrology; 2023 Sep; 11(6):1067-1076. PubMed ID: 36604313
[TBL] [Abstract][Full Text] [Related]
11. Testosterone supplementation in men: a practical guide for the gynecologist and obstetrician.
Owen RC; Elkelany OO; Kim ED
Curr Opin Obstet Gynecol; 2015 Aug; 27(4):258-64. PubMed ID: 26107780
[TBL] [Abstract][Full Text] [Related]
12. Testosterone Replacement Therapy Versus Clomiphene Citrate in the Young Hypogonadal Male.
Scovell JM; Khera M
Eur Urol Focus; 2018 Apr; 4(3):321-323. PubMed ID: 30131284
[TBL] [Abstract][Full Text] [Related]
13. Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets.
Ip FF; di Pierro I; Brown R; Cunningham I; Handelsman DJ; Liu PY
Eur J Endocrinol; 2010 Feb; 162(2):385-90. PubMed ID: 19903801
[TBL] [Abstract][Full Text] [Related]
14. Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism.
Shabsigh A; Kang Y; Shabsign R; Gonzalez M; Liberson G; Fisch H; Goluboff E
J Sex Med; 2005 Sep; 2(5):716-21. PubMed ID: 16422830
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of clomiphene citrate treatment in young hypogonadal men.
Katz DJ; Nabulsi O; Tal R; Mulhall JP
BJU Int; 2012 Aug; 110(4):573-8. PubMed ID: 22044663
[TBL] [Abstract][Full Text] [Related]
16. Testosterone supplementation does not worsen lower urinary tract symptoms.
Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
[TBL] [Abstract][Full Text] [Related]
17. Clomiphene citrate is safe and effective for long-term management of hypogonadism.
Moskovic DJ; Katz DJ; Akhavan A; Park K; Mulhall JP
BJU Int; 2012 Nov; 110(10):1524-8. PubMed ID: 22458540
[TBL] [Abstract][Full Text] [Related]
18. Clomiphene citrate: A potential alternative for testosterone therapy in hypogonadal males.
Huijben M; Lock MTWT; de Kemp VF; Beck JJH; De Kort LMO; van Breda HMK
Endocrinol Diabetes Metab; 2023 May; 6(3):e416. PubMed ID: 36998229
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of enclomiphene and zuclomiphene in men with hypogonadism on long-term clomiphene citrate treatment.
Helo S; Mahon J; Ellen J; Wiehle R; Fontenot G; Hsu K; Feustel P; Welliver C; McCullough A
BJU Int; 2017 Jan; 119(1):171-176. PubMed ID: 27511863
[TBL] [Abstract][Full Text] [Related]
20. Characterising the safety of clomiphene citrate in male patients through prostate-specific antigen, haematocrit, and testosterone levels.
Chandrapal JC; Nielson S; Patel DP; Zhang C; Presson AP; Brant WO; Myers JB; Hotaling JM
BJU Int; 2016 Dec; 118(6):994-1000. PubMed ID: 27226135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
